Saxena S - Search Results

1

Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study.

Brody AL, Mandelkern MA, Lee G, Smith E, Sadeghi M, Saxena S, Jarvik ME, London ED. Brody AL, et al. Among authors: saxena s. Psychiatry Res. 2004 Apr 30;130(3):269-81. doi: 10.1016/j.pscychresns.2003.12.006. Psychiatry Res. 2004. PMID: 15135160 Free PMC article.

2

Brain metabolic changes during cigarette craving.

Brody AL, Mandelkern MA, London ED, Childress AR, Lee GS, Bota RG, Ho ML, Saxena S, Baxter LR Jr, Madsen D, Jarvik ME. Brody AL, et al. Among authors: saxena s. Arch Gen Psychiatry. 2002 Dec;59(12):1162-72. doi: 10.1001/archpsyc.59.12.1162. Arch Gen Psychiatry. 2002. PMID: 12470133 Clinical Trial.

3

Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression.

Saxena S, Brody AL, Ho ML, Zohrabi N, Maidment KM, Baxter LR Jr. Saxena S, et al. Am J Psychiatry. 2003 Mar;160(3):522-32. doi: 10.1176/appi.ajp.160.3.522. Am J Psychiatry. 2003. PMID: 12611834

4

Cerebral glucose metabolism in obsessive-compulsive hoarding.

Saxena S, Brody AL, Maidment KM, Smith EC, Zohrabi N, Katz E, Baker SK, Baxter LR Jr. Saxena S, et al. Am J Psychiatry. 2004 Jun;161(6):1038-48. doi: 10.1176/appi.ajp.161.6.1038. Am J Psychiatry. 2004. PMID: 15169692

5

Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens.

Brody AL, Mandelkern MA, Olmstead RE, Scheibal D, Hahn E, Shiraga S, Zamora-Paja E, Farahi J, Saxena S, London ED, McCracken JT. Brody AL, et al. Among authors: saxena s. Arch Gen Psychiatry. 2006 Jul;63(7):808-16. doi: 10.1001/archpsyc.63.7.808. Arch Gen Psychiatry. 2006. PMID: 16818870 Free PMC article.

6

Effect of a history of major depressive disorder on smoking-induced dopamine release.

Brody AL, Olmstead RE, Abrams AL, Costello MR, Khan A, Kozman D, Saxena S, Farahi J, London ED, Mandelkern MA. Brody AL, et al. Among authors: saxena s. Biol Psychiatry. 2009 Nov 1;66(9):898-901. doi: 10.1016/j.biopsych.2009.06.011. Epub 2009 Jul 29. Biol Psychiatry. 2009. PMID: 19640507 Free PMC article.

7

FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder.

Brody AL, Saxena S, Schwartz JM, Stoessel PW, Maidment K, Phelps ME, Baxter LR Jr. Brody AL, et al. Among authors: saxena s. Psychiatry Res. 1998 Nov 9;84(1):1-6. doi: 10.1016/s0925-4927(98)00041-9. Psychiatry Res. 1998. PMID: 9870412 Clinical Trial.

8

Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine.

Brody AL, Saxena S, Silverman DH, Alborzian S, Fairbanks LA, Phelps ME, Huang SC, Wu HM, Maidment K, Baxter LR Jr. Brody AL, et al. Among authors: saxena s. Psychiatry Res. 1999 Oct 11;91(3):127-39. doi: 10.1016/s0925-4927(99)00034-7. Psychiatry Res. 1999. PMID: 10641577

9

Brain metabolic changes associated with symptom factor improvement in major depressive disorder.

Brody AL, Saxena S, Mandelkern MA, Fairbanks LA, Ho ML, Baxter LR. Brody AL, et al. Among authors: saxena s. Biol Psychiatry. 2001 Aug 1;50(3):171-8. doi: 10.1016/s0006-3223(01)01117-9. Biol Psychiatry. 2001. PMID: 11513815

10

Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression.

Saxena S, Brody AL, Ho ML, Alborzian S, Maidment KM, Zohrabi N, Ho MK, Huang SC, Wu HM, Baxter LR Jr. Saxena S, et al. Arch Gen Psychiatry. 2002 Mar;59(3):250-61. doi: 10.1001/archpsyc.59.3.250. Arch Gen Psychiatry. 2002. PMID: 11879163

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,907 results

Search Page